Citadel Advisors’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-39,829
| Closed | -$7.56K | – | 7084 |
|
2024
Q1 | $7.56K | Buy |
39,829
+26,011
| +188% | +$4.94K | ﹤0.01% | 5713 |
|
2023
Q4 | $15.5K | Buy |
+13,818
| New | +$15.5K | ﹤0.01% | 5442 |
|
2022
Q4 | – | Sell |
-175
| Closed | -$43K | – | 6886 |
|
2022
Q3 | $43K | Sell |
175
-83
| -32% | -$20.4K | ﹤0.01% | 5366 |
|
2022
Q2 | $118K | Buy |
+258
| New | +$118K | ﹤0.01% | 5219 |
|
2021
Q4 | – | Sell |
-35
| Closed | -$56K | – | 7384 |
|
2021
Q3 | $56K | Buy |
35
+27
| +338% | +$43.2K | ﹤0.01% | 6087 |
|
2021
Q2 | $14K | Sell |
8
-147
| -95% | -$257K | ﹤0.01% | 6332 |
|
2021
Q1 | $327K | Buy |
+155
| New | +$327K | ﹤0.01% | 4956 |
|
2020
Q4 | – | Sell |
-72
| Closed | -$49K | – | 5718 |
|
2020
Q3 | $49K | Buy |
72
+67
| +1,340% | +$45.6K | ﹤0.01% | 4400 |
|
2020
Q2 | $6K | Buy |
+5
| New | +$6K | ﹤0.01% | 4566 |
|
2019
Q1 | – | Sell |
-5
| Closed | -$13K | – | 5144 |
|
2018
Q4 | $13K | Buy |
+5
| New | +$13K | ﹤0.01% | 4370 |
|
2018
Q3 | – | Sell |
-4
| Closed | -$13K | – | 4828 |
|
2018
Q2 | $13K | Sell |
4
-3
| -43% | -$9.75K | ﹤0.01% | 4099 |
|
2018
Q1 | $36K | Buy |
+7
| New | +$36K | ﹤0.01% | 3791 |
|
2017
Q4 | – | Sell |
-4
| Closed | -$32K | – | 4361 |
|
2017
Q3 | $32K | Buy |
+4
| New | +$32K | ﹤0.01% | 3456 |
|
2017
Q1 | – | Sell |
-2
| Closed | -$36K | – | 4273 |
|
2016
Q4 | $36K | Hold |
2
| – | – | ﹤0.01% | 3356 |
|
2016
Q3 | $39K | Sell |
2
-3
| -60% | -$58.5K | ﹤0.01% | 3322 |
|
2016
Q2 | $69K | Buy |
5
+3
| +150% | +$41.4K | ﹤0.01% | 3014 |
|
2016
Q1 | $33K | Buy |
+2
| New | +$33K | ﹤0.01% | 3070 |
|
2015
Q3 | – | Sell |
-1
| Closed | -$22K | – | 4358 |
|
2015
Q2 | $22K | Sell |
1
-1
| -50% | -$22K | ﹤0.01% | 3570 |
|
2015
Q1 | $41K | Buy |
2
+1
| +100% | +$20.5K | ﹤0.01% | 3420 |
|
2014
Q4 | $44K | Buy |
+1
| New | +$44K | ﹤0.01% | 3424 |
|